why choose us

First received: December 09, 2022

Clinical Trial: Study With Immunotherapy Combinations in Participants With Metastatic Non-Small Cell Lung Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced Non-Small Cell Lung Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase II, Open-label, Platform Study, to Evaluate Immunotherapy-based Combinations in Participants With Advanced Non-Small Cell Lung Cancer

Brief Summary: The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tolerability of immunotherapy-based combination therapy.

Read more